Ancora Advisors’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-7,125	Closed	-$225K	–	1313
2020 Q1	$225K	Buy	7,125 +4,875	+217%	+$154K	0.01%	604
2019 Q4	$134K	Buy	+2,250	New	+$134K	0.01%	716